OncoDNA, a company specializing in precision medicine for the treatment and diagnosis of cancer, is offering the possibility of using the OncoKDM Lite , a Clinical Decision Support solution, for free for as long as the special containment measures linked to the COVID-19 pandemic are maintained*.

This online platform allows the genomic analysis of any patient to be interpreted quickly, easily and without leaving the office. With it, it is also possible to network specialists from around the world and share each case anonymously, with just a few clicks and from any geographical point that has an internet connection.

“OncoKDM Lite is very useful for connecting laboratories, biologists, pathologists and oncologists to each other. In fact, the platform has a ‘virtual laboratory’ that team members can join and discuss specific cases with all their associated information through an internal messaging system”, says Jean Pol Detiffe, CEO of OncoDNA.

This new platform can group all the information that has been collected about a patient (results of any genomic technology, clinical information, etc.), analyse and interpret it effectively from the clinical and biological point of view, facilitating oncologist decision-making when choosing the ideal therapy for the patient, searching for clinical trials available in the country of origin. And thus offering a faster, more concise and operational response in the regular clinical practice.

More information:
Gema Lloret gema@alivecomunicacion.com +34 630 78 95 45
Gema López comunicacion@alivecomunicacion.com +34 606 1789 71

About OncoDNA

OncoDNA is a private, oncology-focused healthcare technology company that combines advanced, comprehensive testing of all clinically relevant cancer biomarkers (DNA, RNA and protein profiles) from both solid and liquid biopsies, using a proprietary cancer treatment knowledge database called OncoKDO™. The database ‘learns’ continuously from cutting-edge, validated scientific and medical advances. This one-stop-shop analysis and interpretation service gives oncologists actionable results to enable the selection of treatments tailored to an individual patient’s cancer profile. Worldwide, we provide laboratories that have NGS facilities and that would like to reach the same level of expertise with state-of-the-art interpretation software to improve their oncology-oriented routine analyses. The software OncoKDM is a web-based tool that processes oncology raw data from NGS and uses them to give clinical insight into treatment options or clinical trial participation. OncoDNA also works in collaboration with the biopharma industry to develop and deliver the treatments of tomorrow, by assisting with the design, enrolment in and assessment of clinical trials as well as increasing access to approved precision medicines. The company is based in Gosselies, Belgium, and employs 55 staff members in four countries.

For more information please visit: www.oncodna.com

Aubrey Prevot – Product Manager of OncoKDM (OncoDNA) - Aubray Prevot a.prevot@oncodna.com

Report Abuse